FI91484C - Menetelmä uuden solun kasvua säätelevän tekijän, onkostatiini M:n valmistamiseksi - Google Patents

Menetelmä uuden solun kasvua säätelevän tekijän, onkostatiini M:n valmistamiseksi Download PDF

Info

Publication number
FI91484C
FI91484C FI865156A FI865156A FI91484C FI 91484 C FI91484 C FI 91484C FI 865156 A FI865156 A FI 865156A FI 865156 A FI865156 A FI 865156A FI 91484 C FI91484 C FI 91484C
Authority
FI
Finland
Prior art keywords
cells
oncostatin
leukocytes
process according
cell
Prior art date
Application number
FI865156A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI91484B (fi
FI865156A (fi
FI865156A0 (fi
Inventor
Mohammed Shoyab
Joyce M Zarling
Hans Marquardt
Marcia B Hanson
Mario N Lioubin
Thomas Joseph Brown
Original Assignee
Oncogen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen filed Critical Oncogen
Publication of FI865156A0 publication Critical patent/FI865156A0/fi
Publication of FI865156A publication Critical patent/FI865156A/fi
Priority to FI911853A priority Critical patent/FI98373C/fi
Application granted granted Critical
Publication of FI91484B publication Critical patent/FI91484B/fi
Publication of FI91484C publication Critical patent/FI91484C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI865156A 1985-12-20 1986-12-17 Menetelmä uuden solun kasvua säätelevän tekijän, onkostatiini M:n valmistamiseksi FI91484C (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI911853A FI98373C (fi) 1985-12-20 1991-04-17 Uusi diagnostisesti käyttökelpoinen polypeptidi, onkostatiini M

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US81123585A 1985-12-20 1985-12-20
US81123585 1985-12-20
US93528386A 1986-11-26 1986-11-26
US93528386 1986-11-26

Publications (4)

Publication Number Publication Date
FI865156A0 FI865156A0 (fi) 1986-12-17
FI865156A FI865156A (fi) 1987-06-21
FI91484B FI91484B (fi) 1994-03-31
FI91484C true FI91484C (fi) 1994-07-11

Family

ID=27123452

Family Applications (1)

Application Number Title Priority Date Filing Date
FI865156A FI91484C (fi) 1985-12-20 1986-12-17 Menetelmä uuden solun kasvua säätelevän tekijän, onkostatiini M:n valmistamiseksi

Country Status (29)

Country Link
JP (1) JP2559035B2 (de)
KR (1) KR920005920B1 (de)
CN (1) CN1017626B (de)
AT (1) AT400444B (de)
AU (2) AU601168B2 (de)
BE (1) BE905957A (de)
CA (1) CA1340296C (de)
CH (1) CH675727A5 (de)
CY (1) CY1608A (de)
DE (2) DE3645095C2 (de)
DK (1) DK174094B1 (de)
ES (1) ES2003180A6 (de)
FI (1) FI91484C (de)
FR (1) FR2597108B1 (de)
GB (1) GB2185485B (de)
GR (1) GR862936B (de)
HK (1) HK65691A (de)
HU (1) HU210694B (de)
IE (1) IE59415B1 (de)
IL (1) IL81017A (de)
IT (1) IT1213428B (de)
LU (1) LU86718A1 (de)
NL (1) NL8603209A (de)
NO (1) NO174556C (de)
NZ (1) NZ218634A (de)
OA (1) OA08494A (de)
PT (1) PT83986B (de)
SE (1) SE505059C2 (de)
SG (1) SG60891G (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4645828A (en) * 1984-03-23 1987-02-24 Oncogen Platelet related growth regulator
NZ218634A (en) * 1985-12-20 1991-06-25 Oncogen Peptide identified by its cross reactivity with a cell growth factor, dna, antibodies to peptide and test kits
US5681930A (en) * 1985-12-20 1997-10-28 Bristol-Myers Squibb Company Anti-oncostatin M monoclonal antibodies
NZ226799A (en) * 1987-11-06 1991-08-27 Oncogen Breast cancer inhibitory factor and method for inhibiting proliferation of neoplastic cells and compositions therefor
NZ237533A (en) * 1990-03-29 1992-12-23 Bristol Myers Squibb Co Monoclonal antibodies which bind to oncostatin m, cell lines producing them
ZA912137B (en) * 1990-03-29 1992-11-25 Oncogen Monocional antibodies that inhibit growth of kaposi's sarcoma
WO1992002556A1 (en) * 1990-08-02 1992-02-20 Michael Valentine Agrez Human colon cancer cell-derived fibroblast elongation factor
IL107040A0 (en) * 1992-09-25 1993-12-28 Lilly Co Eli Modified platelet factor-4

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4132776A (en) * 1978-02-15 1979-01-02 University Patents, Inc. Delivery of immunologically active components of transfer factor
US4645828A (en) * 1984-03-23 1987-02-24 Oncogen Platelet related growth regulator
NZ218634A (en) * 1985-12-20 1991-06-25 Oncogen Peptide identified by its cross reactivity with a cell growth factor, dna, antibodies to peptide and test kits

Also Published As

Publication number Publication date
DE3643428A1 (de) 1987-09-24
CN86108955A (zh) 1987-12-02
CH675727A5 (de) 1990-10-31
IE59415B1 (en) 1994-02-23
NZ218634A (en) 1991-06-25
DK615386A (da) 1987-06-21
ATA340686A (de) 1995-05-15
AU639048B2 (en) 1993-07-15
HU210694B (en) 1995-06-28
FR2597108B1 (fr) 1991-02-15
NO174556C (no) 1994-05-25
NO865178L (no) 1987-06-22
HK65691A (en) 1991-08-23
HUT43103A (en) 1987-09-28
AU6660886A (en) 1987-06-25
GR862936B (en) 1987-10-28
GB2185485B (en) 1990-07-04
IE863345L (en) 1987-06-20
SG60891G (en) 1991-08-23
NO865178D0 (no) 1986-12-19
DK174094B1 (da) 2002-06-10
PT83986A (en) 1987-01-01
FR2597108A1 (fr) 1987-10-16
IT1213428B (it) 1989-12-20
OA08494A (fr) 1988-07-29
GB8629997D0 (en) 1987-01-28
KR870005645A (ko) 1987-07-06
GB2185485A (en) 1987-07-22
JPS62236498A (ja) 1987-10-16
IT8622787A0 (it) 1986-12-19
DE3643428C2 (de) 1990-08-23
AU6776590A (en) 1991-03-14
JP2559035B2 (ja) 1996-11-27
FI91484B (fi) 1994-03-31
CY1608A (en) 1992-04-03
LU86718A1 (fr) 1988-07-14
AU601168B2 (en) 1990-09-06
DE3645095C2 (de) 1993-11-18
NO174556B (no) 1994-02-14
ES2003180A6 (es) 1988-10-16
DK615386D0 (da) 1986-12-18
IL81017A (en) 1993-01-14
NL8603209A (nl) 1987-07-16
SE8605459D0 (sv) 1986-12-18
CN1017626B (zh) 1992-07-29
CA1340296C (en) 1998-12-29
SE505059C2 (sv) 1997-06-16
BE905957A (fr) 1987-06-17
AT400444B (de) 1995-12-27
SE8605459L (sv) 1987-06-21
IL81017A0 (en) 1987-03-31
KR920005920B1 (ko) 1992-07-24
FI865156A (fi) 1987-06-21
FI865156A0 (fi) 1986-12-17
PT83986B (pt) 1989-07-31

Similar Documents

Publication Publication Date Title
Pober et al. Two distinct monokines, interleukin 1 and tumor necrosis factor, each independently induce biosynthesis and transient expression of the same antigen on the surface of cultured human vascular endothelial cells.
US4816561A (en) Biologically active polypeptides
Woloski et al. Identification and partial characterization of hepatocyte-stimulating factor from leukemia cell lines: comparison with interleukin 1.
US4002602A (en) Ubiquitous immunopoietic polypeptide (UBIP) and methods
US4863899A (en) Biologically active polypeptides
CA2129423A1 (en) Hepatic growth factor receptor
JP2002155100A (ja) 幹細胞増殖因子
Petrides et al. Isolation and characterization of epidermal growth factor from human milk
US5879673A (en) Administration of thrombopoietin on a single day only
FI91484C (fi) Menetelmä uuden solun kasvua säätelevän tekijän, onkostatiini M:n valmistamiseksi
IBRAHIM et al. Reproductive tract secretions and bull spermatozoa contain different clusterin isoforms that cluster cells and inhibit complement‐induced cytolysis
JPS6348299A (ja) 新規な軟骨由来の白血球エラスタ−ゼ阻害剤
US4167557A (en) Ubiquitous immunopoietic polypeptide (UBIP) and methods
EP0363083A2 (de) Pharmazeutische Zusammensetzung zur Behandlung von thrombozytopenischen oder durch Plättchen-Funktionsmangel bedingten Krankheiten
EP0487613B1 (de) Megakaryocytopoietischer faktor
FI98373C (fi) Uusi diagnostisesti käyttökelpoinen polypeptidi, onkostatiini M
US5635356A (en) Anti-oncoimmunin-M antibodies and uses thereof
US5147798A (en) Monophenotypic xenograft of megakaryocytic lineage and origin
JPS6229981A (ja) サルコフア−ガ・レクチンの構造遺伝子
US6294649B1 (en) Method of cell inhibition using polypeptides derived from the venom of the Austrialian jumper ant Myrmecia pilosula
CA1341536C (en) Transforming growth factor peptides
CA1340266C (en) Human pluripotent hematopoietic colony stimulating factor, method of production and use
Shipman The molecular characterization of a common human myelogenous leukemia-associated antigen (CAMAL)
NZ231140A (en) Transforming growth factor (tgf) and its isolation

Legal Events

Date Code Title Description
FG Patent granted

Owner name: ONCOGEN

FG Patent granted

Owner name: METALLEIDO S.R.L.

BB Publication of examined application
FG Patent granted

Owner name: ONCOGEN

MA Patent expired